Treace Medical Concepts
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $47,387 | $52,570 | $68,708 | $45,086 |
Gross Profit | 37,752 | 41,893 | 55,477 | 36,132 |
EBITDA | -13,501 | -12,150 | 3,050 | -11,890 |
EBIT | -16,077 | -14,611 | 813 | -14,047 |
Net Income | -17,398 | -15,922 | -501 | -15,360 |
Net Change In Cash | 47,387 | 52,570 | 68,708 | 45,086 |
Free Cash Flow | -7,817 | 655 | -7,281 | -14,705 |
Cash | 8,052 | 13,372 | 11,350 | 12,110 |
Basic Shares | 63,006 | 62,661 | 62,340 | 62,229 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $209,357 | $187,118 | $141,838 | $94,419 |
Gross Profit | 168,264 | 151,937 | 114,315 | 76,593 |
EBITDA | -42,068 | -39,008 | -36,284 | -15,807 |
EBIT | -50,487 | -44,360 | -38,417 | -16,492 |
Net Income | -55,743 | -49,527 | -42,815 | -20,552 |
Net Change In Cash | 209,357 | 187,118 | 141,838 | 94,419 |
Cost of Revenue | -86,360 | 87,754 | ||
Free Cash Flow | -48,760 | -46,033 | -45,486 | -19,898 |
Cash | 11,350 | 12,982 | 19,473 | 105,833 |
Basic Shares | 62,112 | 60,852 | 55,276 | 54,181 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.28 |
2025-03-31 | -$0.24 |
2024-12-31 | -$0.001 |
